Byron Hoogwerf, MD, FACE, is a Cleveland Clinic staff physician in the Department of Endocrinology, a member of the Cardiology Prevention Clinic and of the Transplant Center, and Program Director for the Internal Medicine Residency Program. He is board certified as a Diplomate by both the American Board of Endocrinology and the American Board of Internal Medicine. His specialty interests include the treatment of diabetes, lipid disorders, and general endocrinology.
A native of Minnesota, Hoogwerf received his medical degree at the University of Minnesota. He completed his internship and residency at the Hennepin County General Hospital in Minneapolis, followed by a fellowship in endocrinology from the University of Minnesota Medical School. He spent four years on the faculty staff of the University of Minnesota Medical School before joining the Cleveland Clinic in 1985 as a staff physician in the Department of Endocrinology.
Hoogwerf has had several academic appointments and is currently a Professor of Medicine at the Cleveland Clinic Health Services Center of the Ohio State University and a Clinical Professor of Medicine at Penn State University.
Hoogwerf's primary clinical and research interests are diabetes mellitus and lipid disorders. He has been actively involved in several large multi-center clinical trials including Post CABG, HOPE, HOPE-TOO, ACCORD and DREAM. He has received funding for his research from the National Institutes of Health (NIH) and served as Principal Investigator in the "ACCORD Trial," a large clinical trial designed to study the effects of glucose control, blood pressure control and lipid treatment on heart disease risk in patients with diabetes. As well, he was Principal Investigator for the eight-year NIH-funded "Post CABG Study-Clinical Centers." In 2000, Hoogwerf was named to Who's Who in America and Who's Who in the World.
A long-time member of the American Diabetes Association (ADA), Hoogwerf was a member of the ADA's national board from 1998-2001. He is a current member of the Physician Recognition Committee. Hoogwerf also served as President of the Diabetes Association of Greater Cleveland.
Widely published in peer-reviewed scientific journals, Hoogwerf serves as an ad hoc reviewer for such publications as Diabetes, Diabetes Care, the Journal of Laboratory Clinical Medicine, the New England Journal of Medicine, the Journal of Endocrinology Metabolism, the Cleveland Clinic Journal of Medicine, the Journal of Women's Health, Drugs and Aging, and the Journal of the American Medical Association. He is the author of more than 220 articles and abstracts in scientific journals and clinical trials publications, many of them related to diabetes, lipid disorders, and coronary bypass surgery. In addition , he has authored 27 chapters in textbooks related to his specialty interests. He has been an invited lecturer or guest speaker at national symposiums, conferences and workshops.
Hoogwerf is Fellow of the American College of Physicians, a Fellow of the American College of Endocrinology, a charter member of the American Association of Clinical Endocrinologists, and holds memberships in the Endocrine Society, and the American Diabetes Association.